Our Work

EMIG works with the NHS, patients, regulators and industry on key issues impacting the pharmaceutical sector. We work in collaboration with policy makers to ensure patients have access to the most effective and innovative medicines and to foster an environment which allows small to medium-sized companies to flourish in the UK.

Below are just some of the priority issues identified by our Membership: 

  • Understanding and working with the new NHS
  • Ensuring patients have equal and prompt access to medicines
  • The economic environment for pharmaceuticals in the UK
  • The implications for patient access to medicines in the devolved nations
  • The impact of existing and future EU legislation
  • EU and UK regulation for medicines
  • Medicines for rare diseases
Cookie Policy | Terms and Conditions | Privacy Policy
Copyright © Ethical Medicines Industry Group 2013 | Ethical Medicines Industry Group (EMIG), 120 Pall Mall, London SW1Y 5EA